探索用于缺血性心脏病和心力衰竭的强化细胞疗法。
Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure.
作者信息
Madonna Rosalinda
机构信息
Department of Pathology, Cardiology Division, University of Pisa, C/o Ospedale di Cisanello, Via Paradisa 2, 56124 Pisa, Italy.
出版信息
J Clin Med. 2022 Jul 1;11(13):3837. doi: 10.3390/jcm11133837.
Abstract
Ischemic heart disease (IHD) and heart failure (HF) remain the leading causes of death worldwide [...].
摘要
缺血性心脏病（IHD）和心力衰竭（HF）仍然是全球范围内的主要死因[...]。
相似文献
1
Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure.探索用于缺血性心脏病和心力衰竭的强化细胞疗法。
J Clin Med. 2022 Jul 1;11(13):3837. doi: 10.3390/jcm11133837.
2
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF.全球急性心力衰竭中缺血性心脏病负担和治疗的差异：REPORT-HF。
JACC Heart Fail. 2021 May;9(5):349-359. doi: 10.1016/j.jchf.2020.12.015. Epub 2021 Apr 7.
3
Incidence of heart failure among diabetic patients with ischemic heart disease: a cohort study.糖尿病合并缺血性心脏病患者心力衰竭的发生率：一项队列研究。
BMC Cardiovasc Disord. 2020 Apr 19;20(1):181. doi: 10.1186/s12872-020-01457-6.
4
Impact of diabetes on heart failure incidence in adults with ischemic heart disease.糖尿病对缺血性心脏病成年人心力衰竭发病率的影响。
J Diabetes Complications. 2017 Nov;31(11):1597-1601. doi: 10.1016/j.jdiacomp.2017.07.011. Epub 2017 Aug 3.
5
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.射血分数保留、中等范围和降低的心力衰竭患者中缺血性心脏病的意义：一项全国性队列研究
Circ Heart Fail. 2017 Jun;10(6). doi: 10.1161/CIRCHEARTFAILURE.117.003875.
6
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.2 型糖尿病与缺血性和非缺血性心力衰竭的预后意义。
J Am Coll Cardiol. 2016 Sep 27;68(13):1404-1416. doi: 10.1016/j.jacc.2016.06.061.
7
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.缺血性心力衰竭（AIMI-HF）影像 HF 项目 I-A 中的替代影像学检查：一项随机对照试验的研究方案。
Trials. 2013 Jul 16;14:218. doi: 10.1186/1745-6215-14-218.
8
Validity of B-Type Natriuretic Peptide, Growth Differentiation Factor 15, and High-Sensitivity Troponin I Levels in Ischemic Heart Failure.B 型利钠肽、生长分化因子 15 和高敏肌钙蛋白 I 水平在缺血性心力衰竭中的有效性。
Clin Lab. 2022 May 1;68(5). doi: 10.7754/Clin.Lab.2021.210751.
9
Predictors of incident heart failure in a cohort of patients with ischemic heart disease.一组缺血性心脏病患者发生心力衰竭的预测因素。
Pan Afr Med J. 2020 Feb 17;35:45. doi: 10.11604/pamj.2020.35.45.18257. eCollection 2020.
10
Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease.2型糖尿病合并新发缺血性心脏病和终末期肾病时发生心力衰竭的风险。
Eur J Heart Fail. 2020 May;22(5):813-820. doi: 10.1002/ejhf.1819. Epub 2020 Apr 4.
引用本文的文献
1
Global ischemic heart disease burden attributable to kidney dysfunction from 1990 to 2021 and projections to 2050: results from the global burden of disease study 2021.1990年至2021年全球因肾功能不全导致的缺血性心脏病负担及到2050年的预测：全球疾病负担研究2021的结果
Front Cardiovasc Med. 2025 May 23;12:1601549. doi: 10.3389/fcvm.2025.1601549. eCollection 2025.
2
Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease.重塑心肌微环境以增强间充质干细胞介导的缺血性心脏病再生作用
Front Bioeng Biotechnol. 2024 Sep 20;12:1468833. doi: 10.3389/fbioe.2024.1468833. eCollection 2024.
本文引用的文献
1
Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion.端粒酶/心肌细胞表达的间充质细胞诱导缺血/再灌注后心脏基质细胞的存活和心血管标志物的表达。
J Cell Mol Med. 2021 Jun;25(12):5381-5390. doi: 10.1111/jcmm.16549. Epub 2021 May 5.
2
Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair.端粒酶/肌球蛋白结合蛋白 co 表达间充质细胞移植促进小鼠心肌血管再生和组织修复。
Vascul Pharmacol. 2020 Dec;135:106807. doi: 10.1016/j.vph.2020.106807. Epub 2020 Oct 31.
3
Aging affects the in vivo regenerative potential of human mesoangioblasts.衰老是影响人体间充质成肌细胞体内再生潜能的一个因素。
Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12714. Epub 2018 Feb 4.
4
Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.心脏兴奋-收缩偶联的生理性、病理性和治疗性旁分泌调节。
Circ Res. 2018 Jan 5;122(1):167-183. doi: 10.1161/CIRCRESAHA.117.311589.
5
European Society of Cardiology: Cardiovascular Disease Statistics 2017.欧洲心脏病学会：《2017年心血管疾病统计数据》
Eur Heart J. 2018 Feb 14;39(7):508-579. doi: 10.1093/eurheartj/ehx628.
6
Cardiomyocyte Regeneration: A Consensus Statement.心肌细胞再生：一份共识声明。
Circulation. 2017 Aug 15;136(7):680-686. doi: 10.1161/CIRCULATIONAHA.117.029343. Epub 2017 Jul 6.
7
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity.2型糖尿病中的细胞衰老：一个治疗契机。
Diabetes. 2015 Jul;64(7):2289-98. doi: 10.2337/db14-1820.
8
Preparing the ground for tissue regeneration: from mechanism to therapy.为组织再生做好准备：从机制到治疗。
Nat Med. 2014 Aug;20(8):857-69. doi: 10.1038/nm.3653.
9
Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.过表达端粒酶和心肌营养素的间充质细胞移植促进了小鼠后肢缺血模型中的血管生成和组织修复。
Circ Res. 2013 Sep 13;113(7):902-14. doi: 10.1161/CIRCRESAHA.113.301690. Epub 2013 Jun 18.
10
Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells.肌球蛋白关联蛋白 A 在不抑制脂肪组织来源的间充质干细胞端粒酶活性的情况下增强前体细胞基因的表达。
Int J Cardiol. 2013 Sep 10;167(6):2912-21. doi: 10.1016/j.ijcard.2012.07.017. Epub 2012 Aug 11.
Zotero 插件